Kaitlyn Min
Family · Pasadena, CANPI 1932668423
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.8%), travel and lodging and gifts — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Edwards Lifesciences at 35.1% of the total. Reporting peaked in 2022 at $4,624 and has fallen 85.0% since, to $694 in 2025. Among family clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 182 payments — averaging $50.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$3K
- Medtronic$3K
- Lantheus Medical Imaging, Inc.$891
- Boston Scientific$456
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$393
- Abiomed$371
- plus $1K from 17 others
What the payments were for
- Travel & lodging$3,81941%
- Food & beverage$5,36858%
- Education$180%
- Gifts$751%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 31 | $3,261 |
| Medtronic | 34 | $2,523 |
| Lantheus Medical Imaging, Inc. | 24 | $891 |
| Boston Scientific | 15 | $456 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 16 | $393 |
| Abiomed | 6 | $371 |
| Novartis | 18 | $248 |
| Shockwave Medical, Inc | 1 | $159 |
| Abbott | 3 | $152 |
| Chiesi USA, Inc. | 5 | $137 |
| Esperion Therapeutics, Inc. | 5 | $113 |
| Penumbra, Inc. | 1 | $110 |
| E.r. Squibb & Sons, L.L.C. | 4 | $88 |
| Amgen | 5 | $81 |
| Veryan Medical Incorporated | 3 | $60 |
| Boehringer Ingelheim | 2 | $58 |
| Johnson & Johnson | 3 | $55 |
| Teleflex LLC | 1 | $24 |
| Amarin Pharma, Inc. | 1 | $23 |
| Akcea Therapeutics, Inc. | 1 | $23 |
| Siemens Medical Solutions USA, Inc. | 1 | $20 |
| AstraZeneca | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,281 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 32 | $283 |
Paid to pharmacies, not to this prescriber.
Other family in Pasadena
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Erin DwyerSan Diego$189K
- Phyllis CasonLos Angeles$187K
- Gabriel SchwartzSan Francisco$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.